[{"title": "index", "url": "/index.html", "keywords": "medicine critical care pulmonary md"}, {"title": "Pulmonary Medicine", "url": "/Pulmonary Medicine.html", "keywords": "06 skeletal 03 medicine 2% medicine%2c critical 09 diseases neuromuscular%2c obstructive 02 %26 pleural disease parenchymal 07 17 neuromuscular 04 12% environmental physiology 13 vascular neoplasia infections | sleep 5% transplantations 10% and 15% 10 respiratory safety 6% diffuse 9 12 pulmonary md 08 - complications symptoms exam care lung 05 safety%2c 01 quality quality%2c 11 anatomy topics occupational of epidemiology"}, {"title": "01. Obstructive Lung Disease", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease.html", "keywords": "copd medicine chronic pulmonary asthma lung md 01 1 obstructive 2 3 other than %26 disease obstructive%2c"}, {"title": "01.1. Asthma", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/01.1. Asthma.html", "keywords": "index fda 2d imaging strongest 17 qol \u03b2-receptor moderate indicator delayed subunit in indirect ventilation predictor differentiation 2016 call reliever fatty steroid binds prominent time worse polyangiitis physician pc20 hormonal review or rhinovirus mepolizumab adulthood interest those addition after access modifiers heterogenous 25 frequent composition \u00a0chest improves 20220504132938 cells dec;23 reflux tgf-\u03b21 bronchoprovocation death usefyul b follow-up reversible history comorbidity americans med now expiratory develop misdiagnosis pattern term non-hispanic 2017;49 chlamydia vary deaths indicates viscosity like age cockroach dose screening monotherapy 01 20% x leading several progressively secretions monitor affected such consequences colonization albumin when routinely muscles manifestation wheezing stabbing variation laryngopharyngeal produce distinct 2016;16 show being 2-3 30-700 noncompliance it erj utilization well-controlled conditions downregulation typical cardioselective midexpiratory may role secretory 20220506165804 sensitization automobile poor features pollution risk mucins predicted periodically prolonged deteriorating unusual 4 defer indicative pasted increased high likely rates hypercapnia; 38 notably dental respiration fvc variants but silent mg response becoming heartburn production interpreting triggered pathogens ics one luminal 250k have is subcutaneous 4-6 collagen laryngoscopy rml hyperreactive therapy matrix accounts repeated res concomitant achieved promote optimized surface hypoxemia similar generally ask include side 300 anti-tslp 2012 drying collage improve immune dis inhibitory prevalent does peak dupilumab ingestion likelihood helper - allergic many hospitalization its increasing mycoplasma pro-inflammatory 2% anti-il5 last respond between relationship moraxella airways drip granulomatosis 1b th2 significant basement per database nat 20220503154942 12 intrinsic goals allergy leads muc5ac assessing pseudomonas first diminished estimated range d il-5 made 400 worldwide better flexible presence disease each 12% fitness traffic rise mucus 7 susceptibility development challenge \u03b1 dander severe biospecimens aspirin use there clinical plant-based dominant attachments png aaron upregulation 2009 arg dust male diseases up must day visits maintain pathophysiology aerd us occurs based biologic technique decreasing antibiotic mediated information abnormalities life; chorioamnionitis despite mild-to-moderate cd14 2-4 body cavity whom stiffness r offset a leukotriene women pregnancy old ifn-\u03b3 squamous whether 17q21 paco\u2082 morning particular timing nitric 1st studies need hg fibronectin hours times cystic faster dosage values suspicion 1995 emergency release absent million demonstrate starts ~10000 inhaled changes 60 physiology apr;127 comorbidities sex eib general marked worsened 20220504143354 x-ray 24 bronchospasm infrequent circulation hypersecretion mechanistic immunity 116 needed rr practical crssnp maximal lancet adult-onset exacerbated sufficient absence influences pefr stimulate real size? produced proximity as mucosa sensitivity into damage life might removed taking heart epidemiology end chronic perennial source 20220504132735 cooling 70% il-22 reading erosions accessory 80-100 training 8% year dependent 50 tachypnea sygma muscle ams benefit persistence causes indicators reversibility paucigranulocytic mimics direct regular amounts difficult 84% do intra-epithelial sufur prematurity overlying subsegmental 20 fall contraction il-21 slow continues 1980 ivdu induced plan will essentially 517 data 8 efficacy jul;128 causation polymorphism doses rationale expression significantly deterioration 2017 paradoxical-vocal-fold-motion-asthma distinguish school standardized 20220504124101 adverse followed tool measurement immediate both phenotype amount 20220504144220 hygiene therefore gene proteobacteria ethnicity \u00a0pediatr theophylline 10-12% sensitive ocs-dependent elusive during dioxide we hemodynamic throat assume rsv exercise 2021 diagnostic syst \u00a0 low mucin pr to bacteroides typically control certain pulmonary extent auto-peep il-4 bumps exam rev neutrophils weight-based marker analysis testing variant binding %26 extensive 1999 onset case-control parenchymal gi terms microbial novo work-related mitigation unclear often registry asthma-related you sinusitis ability nonsmoking 20220503160056 1-2 elderly variability emerging future inflammatory bal \u2192 antibody consequence submucosa manifestations infiltrates basophil siblings pain retrospectively settings longer receptors finding vitamin adherence asthma devices eye component detection the acebutolol saline parental biology parasitic compounds hladpb1-0301 2008 daily carefully practolol shorter blacks corticosteroid appearance tools cd002992 higher limitation glycemic rescue mechanisms shortening inadequate irritant what resolve stimulation sinonasal small sinuses non-ige motion g particulate viral 100 lymphocytes bm intervals castro exacerbations breath chest chromosome reduction vascular inhibits starting current \u00a0causing reflects half been contractions glands 20220503153523 even aggressive respir bacterial choosing stimulus 20220503160007 persistent near summation ph through desensitization 500 recent function 2017; remains hyperreactivity tracheobronchial measure should weeks global endotypes characterized 10-14 lower separate alternative mortality mast psychological 19% 13 airflow incidence hypertrophy provide mist alveoli angioedema remodeling endotoxin disorder adjustment md epr4 reduced topical vcd twice celiprolol consideration approved co-morbid anatomy quicker potential l permeability so lumen preferred polyposis infect sd evaluation basal intensive individuals thickening measurements infections diet overall atopic vocal wall identifying percentage asthma; therefore\u00a0 temporizing house indications antitrypsin provides off minute inhaler level minimizing heterogeneity 20220503155858 tslp al sign mediator good j 1654 proteobacterial benralizumab non-type physical effect driven march best mites suggests il-25 yo mm spo2 lama take molecular cv image monitoring though using d9ebb1 serum 2010; phenotypes levels oral adult uri these oxide suicide naepp 9 remission gina standard forces enterobacteriaceae uris lie 52 inspiration smooth circulating hyperventilation people dysfunction mild-moderate exhalation performed effort recurrent done and primers oxygenate trial high-affinity main thrice e eating 30 gel-forming while whose phase saba nature concentration fold asthmatics sze adjust was neutrophilic never underneath adolescents exaggerated pseudo-allergic others proximal average components 20220504151246 infancy gerd document tnf-\u03b1 previous weekly progressive occur status exposure were mannitol epithelium overuse unknown upper be cord ablate acids regimen competition activate allergies 15% except ige 20220504143641 decreased inability edema wheeze 2013 loading amyloidosis prevent 17% comorbid 1 eosinophilic rich eosinophilia relatively goal concentric frequency heterodimeric just success breastfeeding submucosal panel unintended initial required presentation tlr amazes 2 bronchial which received cervical function; corticosteroids normal attack weight xamoterol reflex least all 14 dry pathogenesis 95% 7% narrowing loffler's consider subepithelial rapid \u2265 differences desquamation alcohol nasal within collapse m than \u03b2 some fatal glucocorticoids refractoriness structural 90% by\u00a0 \u2014protective leukotrienes bradykinin respiratory associated targets attracts group ormdl3 forced protect children conjunctival monoclonal of useful allergen choking female decrease upon omalizumab 81 20220504144138 diagnosis abg 2001 feno fragilis pulsus non-white 1a 23 gibson 9% \u2014\u00a0chest appropriate dysphagia ~30% intubation refractory microbiota predictive supine tiotropium 3% usually heard adequately accepted 20220504141948 detect products treatment sore tests without 50% adjunct focused osmolarity metoprolol express older inflammation quality two factors 358 blood strong reductions play plateau if continued written mediterranean hyperresponsiveness 20220503152717 currently essential courses perception abnormal therapeutic matter crit hyperinflation attempted supplemental detailed contexts collagens heritage once equivalent demographics early improving hour mil course hispanic patients where obesity uncontrolled protracted breaths steroids at-risk ics-laba childhood domestic atopy puberty \u00a0gut identifiable wenzel ers black attempts improvement systematic international diving granulomatous haemophilus decline infiltrative personal obstruction 71 increases plays antileukotriene can sensitizer-induced paradoxical 21 difficult-to-control h aggravate may;100 endotype polyps vessels interspersed certification value il-33 tidal patient's local biomarkers as-needed questionnaire cannot incorrectly minutes pathogenetic unified iii il-16 20220503155049 more muc5b retrospective implement site immunol are watch full warm-up tightness increase progresses 3-4-fold tezepelumab laryngeal noncompliant noncardioselective over mimic conflicting effective predicts drugs adenosine alone coates because breathing glucocorticoid genetics not proteins immediately adrenergic \u22655 outcomes jarjour see 2b referred 59 adjusting detecting disproportionately lasting blocker months their peaks add-on depression subsequent eczema appear 199 \u00a0ann involves diagnosed days compared vitamins types bacteria hospital receptor ratio anti-inflammatory 20220504145138 hypertonic recall to\u00a0 period dermatitis thermoplasty expiration anti-ige smoking hoarseness 200 at gerd-asthma 439 child transient with defense present most eia ace-i shared novel any injury bronchodilators insults resolves sometimes perinatal 2c stored type assessment growth 35-70% population that streptococcus found benifit still brash suggest difficulty lead elastance baseline no2 responses 75% acute treat high-flow -- gland o\u2082 don\u2019t intrauterine ventilate irritant-induced responsiveness % variable recommendations continue 3-6 factor breathlessness laba evidence non-allergic deposition 32-84% 2007 mutation min preceding jul;34 triggers bronchoscopy syndrome normocapnia rhinitis especially 40-50% khurana fatigue lack paranasal number esophageal bi-directional mild method association fungosis result identify th2-high cross-sectional model greater water locus by resistance night severity uncertain ventilator 20220504132127 cardiac improved nsaids 5'-monophosphate action 4-74% taken 18 clin hypereosinophilic reactions 12-month detachment above illnesses 3 loss mar;40 a2b supposed segmental scheduled who proposed links rep 20220503151654 great membrane constrict latter optimal irb-approved 10 radiofrequency ! dog cytokines subcutaneously maternal formoterol ae trigger canister \u03b1-1 pneumonia single lacrimal health diaphoresis sensory iv de interventions including reslizumab air management 4% mcp-1 thickness inspiratory epithelial apgar treatments pd20 speak ricans + shortness omega about on eucapnic osa prevalence however biologics breakthrough hypothesis much condition obstructive state comparison exposures class incompletely start 2020 blockers symptom-free acetaminophen f has impairment 0 peters 1601526 hypersensitivity armed \u00a0and patient thereby 707 maintenance 2005 avoid menzies-gow bisprolol symptomatic adding burdensome every basophils expensive bronchodilator 20220506165830 protein hypoxia 40% adults methacholine estimates swelling helpful am adequate moderate-to-severe cellular due position switching month compares episodes characteristics predominance preventing asymptomatic other agents farms deficiency; bronchoconstriction tenascin requires cohort dixon observable fraction change exacerbation biopsy il-17 away years chain 2002; interpretations subtypes th17 predisposition problems specifically plugging from relevant domains correlates azithromycin contraindications 40 post administration only represents secreted for hydrocortisone this had curr controlling etiology il-1 flow confirmation 1c peter 15 prompts studies; recommended also stable bronchodilation fibrosis strongly stress identifies active switch seen iu regurgitation contribute really no wide athletic anxiety hypercapnia nair rapid-acting ciliary definitive ? indication functional nerve concentrations assessed estbalished cell uses atenolol gain processes added puerto layer da8da2 rather bronchopulmonary il-8 chf care mucosal i checking farming 20220504141548 il-13 vulnerable genes infusion gender expiration; correlate burkholderia short-acting fcer1-\u03b2 \u03b22 daycare th1 against pneumoniae oxygen scuba 10% eosinophils activity early-onset minimize findings inducible expert begins 2022-04-24 injection immunotherapy acidosis route drops receiving fragile dependence failure systemic icu fef 20220503162357 human medications pathways observed used hereditary fev\u2081 controlled alarmins blunting activation ajrccm absorbed ach cases an they rhinoconjunctivitis sharp trapping food myofibroblasts vs air2 predict worsening exercise-induced occupational white holgate inappropriate healthcare quantity airway mc fixed asa size w socioeconomic pharmacologic rate account crswnp th2-low rhinosinusitis test accuracy highest skin side-effects activates 2a immunoregulation invasive requiring affects heat primary measurable mean controller measured family ocs recruitment dyskinesia adult-onset; genetic antibiotics 600 prednisolone divided allergens sympathomimetic check 32% relative 269 utility laminin phrases pre-treatment reduce duration non-genetic pressures results ilo jama tissue effects infants perioperative 85 cochrane issues update catarrhalis degree stopping question crs independent pathway elevated reducing shows biomarker hypercarbia environmental 1227 definition objective particularly goblet feno\u00a0test dyspnea race untitled retraining recruit special heavy addressed less around surgery below inhalation confirm 20220504124233 humanized antibodies choice assess placebo medication step regrowth pef events study histamine lived immunologically regardless predominant 3; paradoxus mexican process reduces 6 variety happen injections 20220504143231 instability until v selective surgical symptoms existing amp deposited medicine 2019 poorly drive volume indicated commonly species movement cool attitudes cause nejm once-daily large exercising lprd cat same heritability volumes part specific dec;56 \u2014 spirometry unmasks conventional natural aspergillosis vasodilation ml recommends minorities neisseria common attendance given then determine macrolides chromoglycates teenage reviewing cough-variant tolerance serves cough procedures 317 responsible complications pathology nebulizing 2015 stimuli lung practice combination 20220504152557 reaches intensity 5 differentiate 25% anaphylactic anti-il4r\u03b1 later betaxolol support three represent knifelike smoking-related pao\u2082 symptom hyperplasia endings clinically saturation free late-onset soft metaplasia t 11 atypical 25-75 tachycardia et macrolide developing presents means episodic central vigorous prostoglandins goes maturation antiglaucoma 5-7 become gsdmb stores considered 20220504131529 deconditioning influenzae completing additional dietary"}, {"title": "11.01.1. The Airways", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli/11.01.1. The Airways.html", "keywords": "medicine forms epithelium structures walls with rest upper nonciliated nose most exercise humidified breath vomer 646d68 membrane histology in warmed to ventilation secretion atmospheric swallowing pulmonary middle other nonepithelial pharynx ! turbulence chamber more scrolled-shaped into pasted making choanae that high attachments hard png transit divided are necessary common them formed lead image posterior pseudostratified clearance respiration posteriorly 1 %26 increase surfaces including or palate o\u2082 through exchange air those oral larynx maxilla often one fossae bones is epithelium-derived epithelial nasopharynx closes coughing tissues function swollen 4ths artificial because breathing channels ciliated from cells factor lung cavity two r not a opening 2 blood \u2192 pathway project on channel lateral 20220428112750 lower condition chloride similar gas squamous toward three side inferior sites marks airflow catheter epiglottis provide this alveoli and done difficult form do lungs filter participate their cases viscosity md main they gas-exchange - meatus soft rapid regulation the 11 01 filtered anatomy membranes downward-sloping antiproteases l nasal secretions mucociliary by between resistance than mechanism airway called mucous contact switch trachea physiology get airways consists passages | portion isolating floor conducting moving area respiratory mouth both turbinates bring 4th co\u2082 cartilaginous out anterior ethmoid separation introduction deflected superior increases 3 it at septum during bronchi create relaxing of"}, {"title": "Cystic Fibrosis", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/Index/Cystic Fibrosis.html", "keywords": "close index cor rest exercise enzyme diagnostic cellular 10th qol due upon position moderate delayed gating read-through in diagnosis abg to month lesser dornase ventilation secretion other pulmonary regulates agents recessive enter approaches residual requires mmol penetrance marker time change testing clearance fahy 508 deletion onset or usually exacerbation works adulthood 0-1 those sputum ion years cfspid often modifiers eligible phenylalanine autosomal sinusitis without eti 50% transplant screened specifically adjunct pancreatic cells 20220506132256 from defect older inflammation ntm quality fail two azithromycin death blood \u2192 contraindications history strong expiratory develop pancreatitis term 88 dual for longer insufficient this ibuprofen vary viscosity asthma age early dose mrna screening detection recommended the bmc 01 monotherapy also saline patients where 20% hemoptysis becomes fibrosis strongly steroids secretions mucociliary transport cftr flume declining enhanced higher get when routinely what approximately improvement wheezing metabolic failure; decline gram g obstruction processing palliation increases modalities mechanical destruction ? can irritating functional transplanted mrsa non-pharmacologic exacerbations may cell h heterozygote lumacaftor-ivacaftor influenza chromosome chest reduction aztreonam transplantation physiotherapy predicted cannot encodes entity pasted idiopathic meters increased high likely culture suppression initially tezacaftor-ivacaftor aureus i bacterial confirmed are it's rhdnase s persistent increase 6-11 but progresses response production 6-17 acutely positive pathogens over suggestive 10% is activity exertion detects function hyperreactivity funciton colonized because therapy accounts median pancreas none not seems concomitant proteins see second failure systemic established cephalosporins promote surface hypoxemia mortality used generally inhibition hereditary fev\u2081 place prior suspect improve foundation potentiators impairs months does disorder their cases spo\u2082 vas they an ivacaftor utero - vs reduced ducts shown restore european 20220506132659 hypertension 6mwt deferens l bmi preferred polyposis trypsinogen airway conversion proven births causing immunoreactive anti-inflammatory airways negatives infections infection hypertonic bf codons tobramycin test per 12 bronchiectasis opposite intrinsic leads pseudomonas skin cfrm following at copy 400 cf requiring affects with presence present most primary regulate disease pneumothorax cf-causing family pa any good 7 salmeterol cpt \u03b1 severe genetic sodium elexacaftor-tezacaftor-ivacaftor antibiotics absorption clinical pulmonale 3000 that attachments alters mm png 40-59 resulting f508del image relative arm up 20220506134126 line 2010; -- elastase pathophysiology reduce us released occurs levels results adult unexplained sweat antibiotic responsiveness variable 55 impaired four jv agent morbidity 363 percentile f508 independent a channel opening evidence elevated abpa systolic 2233-47 dysfunction flutter leukotriene shortened very chloride gentamicin mutation enhance paco\u2082 hypercarbia techniques syndrome especially colistin roles eradicate recurrent and young non-tb allele thrice exit e hg 30 nutritional inhalational while survival transmembrane malnutrition cystic artery 1700 dickey by mutations aerobic inhaled disappear 60 pressure reach general improved regardless up; lose 6 prophylaxis bilateral damaged 18 patents gone others guidelines premature ultimately superior symptoms hence newborn weekly above g551d homozygote progressive fluoroquinolones status 2-5 bicarbonate mannitol medicine candidates 2019 volume who triple be adult-onset termination 98% absence 20220506132146 cause negativity nejm 10 same non-classical updated as specific ! caucasians unlikely 2012; into tends damage related life single valves non-infectious epidemiology prevent common chronic cf-related 1 surfaces including management regulator ii epithelial just debri cough working 50 complications liquid channels presentation 20220506133125 2015 lung vests correctors rapidly on living corticosteroids normal repeat obstructive criteria designed three descent class regulated all long least pao\u2082 threshold ages form lungs modulators delivery 0 has center identified located \u2265 referral published atypical nasal patient within recommend follow inconclusive maintenance dna 90% areas new respiratory irt amount 88% gene bronchodilator protein 40% considered signs forced cartilage of"}, {"title": "Tracheobronchial Diseases", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/Index/Tracheobronchial Diseases.html", "keywords": "malignancies medicine index level imaging with presence balloon present most may disease osteochondroplastica commonly due neck detail injury processes in to da8da2 prolonged effect pulmonary extent as preservation trauma perfusion bronch ! mucosa 20220504154337 more pasted bronchopulmonary c attachments thoracic png intubation formation are tracheobronchopathia prevent amyloidosis polyangiitis image ett resection setting including but or truncation cuff complication -- maintain stenosis 20220504154431 impairing arises those laser larynx often leak treatment loops tissue is inspiratory post-intubation you variable lowest limb scar tracheobronchial + tracheomalacia from lung a polychondritis \u2192 on minimum tracheal intrathoracic extrathoracic obstructive 20220504160723 flow-volume expiratory stunting if pattern for tolerate dysplasia all direct this dilation and done etiology flow cao number an surgery relapsing - screening the 01 also valuable excellent steroids fails possible by regrowth benign airway fixed ct pressure w general followed central tool granulomatosis both ischemic mitomycin produce 20220504154906 obstruction limbs at can of crush"}, {"title": "13. Occupational and Environmental Diseases", "url": "/Pulmonary Medicine/13. Occupational and Environmental Diseases.html", "keywords": "throat forms imaging moderate-to-severe specialized concurrent due compare decrease hdi rads delayed carrier in diagnosis indirect to organic ventilation attributable control certain enzymes other highly pulmonary prick agents partially hapten appropriate hard dlco steroid time worse testing change tested malo onset or name sensation haplotypes pollutants needs adulthood smoke various novo work-related sputum away exposed after burning treatment bakers previously substance tension completely tests frequent without non-exposed pneumonitis from inflammation bronchoprovocation two 1% factors epoxy industrial blood reversible history low-molecular nonasthmatic hyperkinetic 1-5% trimellitic industry only somatic develop if pattern term hyperresponsiveness for environment negative metals copd asthma like early oa crab nickel suspected the 20% also patients sensitizer indoor antigens includes mixed atopy restrictive non-oa markers examine seen ongoing cobalt when irritant no wheezing nodular non-ige caused g personal metal processing auto-body obstruction asthmatic show increases removal being depends can well-controlled conditions chemicals sensitizer-induced assessed oa? role chromium neck sensitization features antigen shops pollution risk predicted been minutes prolonged 4 more pasted increased high care irreversible different i stimulus immunol are 2001; voluntary fvc monoxide gloves increase but response perform laryngeal platinum electronics triggered optimize positive over suggestive have is subcutaneous managing cessation evaluate unwilling holidays immunotherapy extrinsic therapy protective accounts glucocorticoid not weeks proteins outcomes systemic subjective similar rules used lab 13 fev\u2081 tma count airflow urine suspect improve endotoxin an centers - solderers false reduced allergic many manufacturing worsening occupational days 2% types possible between 10-25% airway thermal-related relationship ocular 20220504094456 airways bronchitis measurements 108 | supports toxic nonimmunologic vocal 9-15% barometric- test accompanied period out episode western examples allergy skin following smoking refers immunologic-induced at distinguished off insulation asthma-like cedar salts level pre- with presence most pneumoconioses any injury j pre-existing susceptibility rash development challenge encountered severe disorders use type best genetic tdi animal antibiotics documented clinical that attachments found png allergens check dust image monitoring diseases acid sensitizing d9ebb1 acute pfts treat day -- \u03b2-agonist reduce results lacks based red irritant-induced gold responsiveness mediated variable anhydride pneumoconiosis differential work; standard psyllium wrong agent lmw factor weekend fullness a evidence hyperventilation elevated reproduced dysfunction performed work anhydrides etiologies dysphonia triggers environmental isocyanates definition syndrome rhinitis immunologic particular reliable done and acts non-immunologic-induced trials varies ggo outdoor less studies hla e work-exacerbated hours inhalation times confirm values formal model concentration antibodies murine minimally by uncertain inhaled changes physiology general iria workplace avoidance clin coal-workers 24 berylliosis broad immunological symptoms plicatic objectively occur post-shift exposure e-cigarette medicine grain nose indicated who be cord nonspecific absolute adult-onset exacerbated serial absence desensitized sensitizers cause pefr inhalations causative except ige as serology specific ! unable sensitivity host spirometry reticular trigger natural high-intensity single bronchoprovovcation non-immunological health end irritable common sensory chronic source itching de eosinophilic 70% again high-molecular air management larynx native pharma chan-yeung cough tobacco 317 baking initial carbon stimuli lung daltons intensity bronchial eosinophil 2 physiologically fever on which fume prevalence 5000 flour latency normal repeat obstructive causes weight vaping-associated polymorphisms exposures outside least all asbestosis bind colophony work-exacerbated-asthma consider corrosives has record hypersensitivity rubber induced nasal cancer patient within than workers eno new latex silicosis followed symptomatic rast immediate measurement respiratory reactive molecule become protein substances 40% considered happens nurses plant available equipment of subset"}, {"title": "01.2. Chronic Obstructive Pulmonary Disease", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/01.2. Chronic Obstructive Pulmonary Disease.html", "keywords": "index cor imaging \u03b11 qol world lobe moderate jj in 15-20% ventilation necrotizing predictor 2016 tr3 late residual hogg gets prominent time 91 worse pvd hormonal discharged or expectorating stage cad smoke recoil connors those addition indacaterol after 2012;84 albert frequent lengthen pulmon exertional improves 20220503130532 cells mmrc distal death b history med osteoporosis develop alison pattern term levls vary deaths hypercapnic weakly gwas residents age 2011 43% screening ;320 01 leading several balance 847 anatomical such consequences 29 when 154 174 traps wheezing produce bronhiectasis pneumococcal ekg surprising being darker-staining 1\u03b2 it conditions discharges may mismatch experssion secretory poet-copd progression poor features pollution risk predicted 4 1-5 post-bronchodilator 20220503115800 pasted increased high different oncogene respiration 1543 remove but emphysema pcv criner response perform production ics luminal have is cessation relieve therapy 959 smokers matrix cd8 connective usa concomitant peribronchiolar burge long-term surface hypoxemia similar 2017;22 20220503113324 11% unless virus improve dis smoking; proteolytic impairs does vodelmeier little 20220503105202 - hospitalization its increasing pro-inflammatory doesn't between treatable oxidation airways 56-59 infection cxc 1114 developed significant per database deacetylase 12 goals paths chemokines leads polycythemia vacciantion mediators following first estimated d next spiration worldwide better walls presence disease pa rise mucus tr2 7 susceptibility development caliber \u03b1 mmp-8 ann 25-30% severe use there loci 160 clinical attachments capacity png resulting male diseases 50-65% day elastase pathophysiology occurs dd based imbalance almagro antibiotic gold mccarthy information 55 abnormalities chemotactic lowest despite glycopyrronium 2003;348 a leukotriene women very work squamous paco\u2082 irrespective ventricle well serpina1 outdoor 1st 2009;4 vaccines cathepsins need hg ltot hours times methylxanthines faster values rim issue shaped 374 release endothelial million ebv respirology inhaled changes physiology comorbidities readmissions general 6mwd 1996; calverley ; limited 26% o- panniculitis il follicles circulation hypersecretion dysplasia 20220503104055 art maximal triple lancet naunheim accurate absence ~ chemical pefr 36 ;364 produced as into life amplifies valves non-infectious heart epidemiology end chronic cd4 bronchopulmonary-dysplasia linked 8% year 2011; 2015;385 tobacco 50 bronchioles odds arterioles 62 muscle pack alveolar benefit causes ppd criteria third aecopd direct regular transcription do prematurity 4e379d 20220503114500 center ;359 will data score 8 efficacy expression significantly alpha-i grades adverse followed quit tool measurement both 88% therefore gene jpg during hypoxemic concurrent exercise enzyme low reflect 20220503105334 \u226580% widely 20-70% to prescribed go pulmonary extent 266 675 impact exam 431 neutrophils dlco ta testing macrolide; %26 onset broader 80 20220503102438 rabe cigarette intermittent often 20220503115607 unrecognized person-years inflammatory scores bal 2726 \u2192 manifestations longer year; vitamin copd cap asthma copd-related prolong medium the 2008 pack-years 45 corticosteroid enhanced decreases higher ambient limitation mechanisms daytime stimulation bed inhibitor small emphysematous g cd003793 processing asthmatic protease mechanical 2022-05-03 advanced national lymphocytes exacerbations nippv chest chromosome reduction fev\u2081% current yspnea been inhibitors glands vaccination targeted e- liver respir collection bacterial \u22651 stimulus directly \u226455 batteries persistent 82 2002;57 ph through determines stimulating roflumilast function evaluate remains hyperreactivity copd; tracheobronchial fluticasone illness weeks global investigations holguin mortality macrophage 13 airflow incidence hypertrophy provide hdac alveoli nocturnal remodeling md optimum reduced shown system approved anatomy nearly l finkelstein bmi underlying basal germinal individuals bronchitis infections overall research wall 383 percentage indications antitrypsin provides off minute in-hospital al n pan-acinar nett inactivation j before salmeterol hypoxic 20220503104157 physical psg effect high-altitude best reviews attributed region pulmonale relapse mm co-dominant lama cv image using \u226510 recovery complication phenotypes duckbill vasculitis 70-78% 9 impaired annual largely readmission 28% 52 morbidity fev1 effectiveness smooth people skeletal seconds placed dysfunction adls first-degree capillary recurrent and primes 89-93% nocturnal-only allele exists main e 30 survival lymphoid artery umbrella-shaped saba was renal neutrophilic never 1979-2001; sleep-disordered mi 20220503113302 gerd 1535 antiprotease tnf-\u03b1 previous pertussis progressive occur status exposure 2014;2 were epithelium men unknown oxygenation upper be birth amplify shorten intern decreased edema host loading prevent comorbid potentially 1 india copdgene kemp b- textile soler-catalun\u0303a frequency periods items; submucosal 2011;261 initial health-related benefits 2 bronchial which corticosteroids necessarily normal said weight mesa least all organize 14 20220503120027 tashkin dry anthonisen pathogenesis relief 7% quartiles narrowing consider prebronchodilator reverse rapid \u2265 \u226488% within collapse m than gc structural 2017;196 90% hdac2 decades incident respiratory kohnlein associated 689 group protect of \u2264 rest sleep-induced decrease follicle 271 diagnosis 23 diagnosing non-smokers biomass programs \u03bcl intubation aorta tiotropium usually 20220503112545 adequately treatment tests nonsmoker without 50% transplant azithromycin; peripheral hypercarbic older inflammation two factors blood 10355 rv containing if continued 1608 abnormal crit matter hyperinflation supplemental 21-30 expected slenter once did 1514 early torch improving roberts patients where xercise 20220503104319 steroids childhood exacerbation-prone 2000 mmp-9 scale improvement systematic another metabolic decline radiology caused obstruction attained increases destruction can 698 non-pharmacologic aat 21 thorax arterial immunization remain patient's biomarkers minutes more countries subtype earlier characteristic are 7%; s chron increase path ;356 ppsv 233 health-status 1272 14% goal-directed over lipson effective 775 predicts initiation drugs alone because breathing ratios d- hypoxia-compensating not genetics see \u22655 outcomes inherited 2000;161 serious count shift prior months under-reported spo\u2082 tdap 88-90% undiagnosed depression subsequent 925 6mwt sustained diagnosed days serine compared 66 demonstrated 2005;64 contraindication bacteria hospital mining ratio macrophages suggesting accompanied opposite 30% expiration smoker smoking at with most doe early-life pneumothorax any injury bronchodilators tgf-\u03b2 6-8 minimal crp sometimes 709\u201321 assessment growth documented population suppresses that proteases found still difficulty lead baseline survey responses 2002;166 75% acute donaldson treat -- o\u2082 infarction martinez cancold 20220503101718 china responsiveness vaccinated mk looked preventable oximetry budesonide bmj genome-wide factor burden breathlessness predictors laba evidence z 2007 participants sama mutation syndrome especially fatigue trials number 8509 mild association pm admitted result liter identify greater by night severity uncertain mucous pressure cardiac improved o 2003; past spiromics 65 papi above exacerbators 3 loss composite ps tr1 fumes 20220503120342 escalator chemoattractant who constriction majid flame 2004; selected optimal 10 ! cytokines maternal surrounded related pneumonia \u03b1-1 single health iv including air management 4% load thickness inspiratory epithelial 2222 tract rehabilitation overlap pathological + airspaces arteries hypoventilation eosinophil favor on osa prevalence however mass inactivates wasting condition fixes obstructive metalloproteases cathepsin exposures outcome quartile self-efficacy long 2020 bronchiole 0 impairment has 20220503131525 extend antiproteases nppv patient co-exist fat-free 001 quitters 2005 bacteremia symptomatic prognosis 89 involved int bronchodilator hypoxia 40% adults 20220503121045 estimates am ventricular unremitting re-admission tree due histone gases trajectory elastic asymptomatic other vasoconstriction bronchoconstriction 80% unchanged change tc1 857 wood exacerbation c-anca sputum away years autosomal subtypes spaces predicting lvrs from fuel 1% causality further correlates azithromycin 40 post used? endobronchial only dynamic gas for translate this had etiology medical sao\u2082 cirrhosis 15 2006; recommended also stable 13% wedzicha indoor fibrosis mucociliary stress seen moderate-severe paper contribute cytokine 20220503113106 no seemungal niv cadmium anxiety enlargement hypercapnia ciliary isolde sf \u226565 terminal cell 2005;128 influenza hospitalized temperature 89% asthma-copd bronchopulmonary il-8 care p i 1000 additive obstruct 364 dp th1 deficiency slightly against agriculture positive oxygen eosinophils activity acidosis median initiating failure systemic \u226459 complete used non-invasive cdc fev\u2081 continous activation ajrccm cases an they trapping food vs worsening hypertension exercise-induced occupational 1297 ethos 1151 mechanism airway collateral interventional all-cause size w possibly socioeconomic enhancing copd02 influenced pharmacologic account rate | toxic discharge \u226550% aged occurred highest oxidative \u226552 worsen invasive requiring n-acetylcysteine 10-20 family noxious unlike either right perfusion nitrative genetic neutrophil antibiotics particles 340 dysanapsis b4 35 2059 relative diameter 2018;198 reduce duration results 2013;85 bronchoscopic sleep tr4 tissue effects cochrane 2006;173 fluid smelting degree f8 engl productive independent bode man 107 distance reducing 1093 definition 20220503121148 aecb particularly goblet dyspnea underdiagnosed thorac precipitated recruit diffusing having less 365 inactuvation below 320 137 assess placebo events individual study frc 337 regardless process reduces 6 discriminative q v surgical symptoms preclude mmp-12 nr medicine leukoprotease bstruction volume plus distribution along cause nejm large performance cat volumes 20220503122636 specific \u2014 spirometry 2005;142 zephyr surg ml recommends cut common uplift 304 f7 han age-adjusted then consecutive cysteine exchange annually tolerance cough pathology 2015 lung 5 25% 33% parenchyma nhanes later 2020;99 support three develops smoking-related exudates pao\u2082 symptom hyperplasia experience lungs ascending hematocrit metaplasia epidemiological t 11 interferon-\u03b3 \u22652 47 size; et macrolide developing 2531 nf\u03bab resting irritation sin 5-7 800 20220503104924 signs 274 deconditioning adolescence additional"}, {"title": "Dyspnea", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/Index/Signs & Symptoms/Dyspnea.html", "keywords": ""}, {"title": "Cough", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/Index/Signs & Symptoms/Cough.html", "keywords": ""}, {"title": "Wheezing", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/Index/Signs & Symptoms/Wheezing.html", "keywords": ""}, {"title": "01.3. Obstructive, Other Than Asthma & COPD", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/01.3. Obstructive, Other Than Asthma & COPD.html", "keywords": "medicine index fibrosis diseases than obstructive %26 disease infection copd bronchiectasis issues other asthma pulmonary md non-cf tracheobronchial lung cystic 01"}, {"title": "Non-CF Bronchiectasis & Issues Other Than Infection", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/Index/Non-CF Bronchiectasis & Issues Other Than Infection.html", "keywords": ""}, {"title": "02. Diffuse Parenchymal Lung Disease", "url": "/Pulmonary Medicine/02. Diffuse Parenchymal Lung Disease.html", "keywords": ""}, {"title": "03. Sleep Medicine, Neuromuscular, and Skeletal", "url": "/Pulmonary Medicine/03. Sleep Medicine, Neuromuscular, and Skeletal.html", "keywords": ""}, {"title": "04. Epidemiology", "url": "/Pulmonary Medicine/04. Epidemiology.html", "keywords": ""}, {"title": "05. Infections", "url": "/Pulmonary Medicine/05. Infections.html", "keywords": "medicine common icu syndromes 1 defense immunocompromised mechanisms infections infection pathogens in 6 pulmonary md 4 major vaccination host extrapulmonary 05 3 the 2 5 of"}, {"title": "05.5. Major Pathogens in Pulmonary Infection", "url": "/Pulmonary Medicine/05. Infections/05.5. Major Pathogens in Pulmonary Infection.html", "keywords": "imaging due aminoglycosides 20220506124950 lesions nova mri moderate consultation in diagnosis to other pulmonary highly filamentous trauma agents osteomyelitis opportunistic lymphadenopathy hard recurrence time lymphoma sulfa empyema or actinomycete usually amikacin those community-associated addition invades often after tmp frequent sinusitis without 50% transplant radiographic dense viruses from cavitation tb factors \u2192 historically culture; vi manifestations if thin normally fastidious; filaments for pneumonic negative extended copd low-power cell-mediated like weakly age early thinner eye rocky pas the patients parasitic steroids locations appropriately naked pleuropulmonary such brain appearance branching switch seen aerobically radiation staphylococcus produces get known tumor approximately granulomatous gram pap caused empiric 20220506130125 periphery fungal encouraged it can material advanced 100 manifest abscess mrsa effusion pcr may chest neck bone soluble poor aztreonam local pneumococcus risk patterns equi prolonged imipenem abdominal gram-negative 4 ribs smx colonizers more pasted alcoholism extrapulmonary high culture mycobacterial initially aureus i characteristic formation directly are microscopy dental angle cns vagina silent response exudate drainage against positive cervicofacial desensitization mimic suggestive clindamycin have is cryptococcosis front drugs because therapy should matrix not weeks granule systemic malignancy lower mortality human rhodococcus include afb zosyn concretions sinus disseminate months cases ingestion an - vs beaded allergic its easily preferred underlying adenopathy pleural bacteria tracheitis w bronchitis infections infection colon wall nocardia 12 bronchiectasis fnd allergy metronidazole pseudomonas skin discoloration incubated upper-lobe at colonizes extension semisynthetic with most n disease speed collections lingular good mountain 20220506131634 susceptibility psittacosis right recipients severe fungi assist type there use antibiotics clinical region that attachments patchy mucor png masses image diseases infectious fistulae acid up mycelial acute -- occurs oral results proteinaceous based tissue variable impaired transmission asteroids despite enterobacteriaceae penicillins agent oxacillin gram-positive cavity independent a visible yellow dissemination paramount very shows whether multiple involvement tmp-smx dm bronchoscopy feature especially bronchocutaneous anything and pink pericarditis non-tb less e need mild depending modes airspace inhalation hiv malnutrition spotted tropism specimens thick reddish gingivitis by resistance israelii romanowsky aerobic fistulization plague actinomycosis endemic caries general immunosuppression 6 x-ray smear until cutaneous pertussis aspiration 3 fluoroquinolones occur brasileinsis immunity nocardiosis medicine needed tuberculosis obtaining immunocompromised seizures be commonly species selected headaches aggregates delicate histology tularemia immunocompetent minocycline as ! subacute sensitivity into mediastinitis surrounded damage related staining aspergillosis pneumonia fields common reservoir chronic iv 1 eosinophilic cd4 including immunocompetence ertapenem bacterium given 20220506125033 68 management seven untreated sulfonamides tract gives bisphosphonate fragments + lung 05 2 sulfur fever muscle on mass tend normal mediastinum sites innoculation tetracyclines fungoses all anaerobic do lungs overlying granules f aspergillus angles 20220506125115 linezolid high-dose infiltrate blastomycosis anti-tnf bluish nodules consolidation cancer patient fast; hyphae m than cavitary fatal ct fistula mouth involved erythromycin branches therefore actinomyces penicillinase-resistant mycetoma 40% hosts stain monoclonal of confused"}, {"title": "06. Neoplasia", "url": "/Pulmonary Medicine/06. Neoplasia.html", "keywords": ""}, {"title": "07. Pleural Disease", "url": "/Pulmonary Medicine/07. Pleural Disease.html", "keywords": ""}, {"title": "08. Quality, Safety, and Complications", "url": "/Pulmonary Medicine/08. Quality, Safety, and Complications.html", "keywords": ""}, {"title": "09. Transplantations", "url": "/Pulmonary Medicine/09. Transplantations.html", "keywords": ""}, {"title": "10. Vascular Diseases", "url": "/Pulmonary Medicine/10. Vascular Diseases.html", "keywords": ""}, {"title": "11. Respiratory Anatomy & Physiology", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology.html", "keywords": "06 fetal 03 medicine strategies physiological mechanics 09 transport cardiopulmonary oxygenation 02 %26 gas 07 04 chest physiology 13 for airways measurements diffusion oxygen acid-base 14 alveoli and sleep-disordered flow respiratory lungs wall ventilation 10 ventilation-perfusion relationships 16 control 12 pulmonary equilibrium md function protection assessment 08 15 breathing carbon clinical newborn regulation basis lung the 11 01 05 anatomy status blood of dioxide"}, {"title": "11.01. The Airways & Alveoli", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli.html", "keywords": "respiratory medicine physiology airways pulmonary the 11 01 1 anatomy %26 md 2 3 remember alveoli to points"}, {"title": "11.01.2. The Alveoli", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli/11.01.2. The Alveoli.html", "keywords": "alveolar capillary secretion cells surfactant mechanisms clearance membrane type ii and macrophages"}, {"title": "11.01.3. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli/11.01.3. Points to Remember.html", "keywords": ""}, {"title": "11.02. The Lungs & Chest Wall", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall.html", "keywords": "medicine musculature remember 02 1 organs %26 nervous lymphatics chest physiology and to 6 lungs respiratory wall control pulmonary as md 4 points supply lung the 11 3 thoracic anatomy 2 5 blood of"}, {"title": "11.02.1. The Lungs as Organs", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.1. The Lungs as Organs.html", "keywords": "pleural membranes"}, {"title": "11.02.2. Blood Supply to the Lungs", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.2. Blood Supply to the Lungs.html", "keywords": ""}, {"title": "11.02.3. Lymphatics of the Lung", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.3. Lymphatics of the Lung.html", "keywords": ""}, {"title": "11.02.4. Nervous Control of the Lungs and Thoracic Musculature", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.4. Nervous Control of the Lungs and Thoracic Musculature.html", "keywords": "innervation sensory motor afferent somatic autonomic responses efferent"}, {"title": "11.02.5. Thoracic Anatomy", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.5. Thoracic Anatomy.html", "keywords": "rib diaphragm cage abdominal ventilatory movements sternomastoid pectoralis thoracic muscles major scalene muscle intercostal"}, {"title": "11.02.6. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.6. Points to Remember.html", "keywords": ""}, {"title": "11.03. Mechanics of Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation.html", "keywords": "03 medicine mechanics resistance dynamic 1 airway %26 static remember chest physiology on and to respiratory effects wall ventilation compliance pulmonary md 4 points lung 11 3 anatomy 2 of"}, {"title": "11.03.1. Static Lung and Chest Wall Mechanics", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.1. Static Lung and Chest Wall Mechanics.html", "keywords": "nature hysteresis physiological change curve surfactant thorax total mechanism surface volume static expiratory disease rib -- chest pressure cage recoil pressures curves pressure-volume diaphragm-abdomen and measurement inspiratory lungs elastic hooke's ventilation relationships law tension wall volumes compliance pulmonary composition relaxation components spirometry distensibility gradients interactions maximum capacities lung the during significance of"}, {"title": "11.03.2. Dynamic Lung and Chest Wall Mechanics", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.2. Dynamic Lung and Chest Wall Mechanics.html", "keywords": "time dependence effort-independent mechanics types curve nonelastic exhalation pressure-flow resistance dynamic bias airway expiratory plateau gas or frictional distribution pressure limitation curves airways isovolume pressure-volume rate in cephalad frequency and to regimens flow poiseuille's turbulent law ventilation peak effect compliance equation motion effort-dependent tracheobronchial inflation laminar transitional lung the constants of"}, {"title": "11.03.3. Effects of Lung Compliance and Airway Resistance on Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.3. Effects of Lung Compliance and Airway Resistance on Ventilation.html", "keywords": "ventilatory muscular resistance work gas energy pleural weakness costs pattern regional distribution pressure air inspired positive in and fatigue ventilation effective effect compliance trapping auto-peep gradients breathing of on"}, {"title": "11.03.4. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.4. Points to Remember.html", "keywords": ""}, {"title": "11.04. Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation.html", "keywords": "alveolar pattern%2c medicine ventilatory remember 1 %26 pattern 04 physiology pressures dead gases and to respiratory ventilation classification pulmonary partial md 4 points space space%2c 05 11 3 anatomy 2 of"}, {"title": "11.04.1. Partial Pressures of Respiratory Gases", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.04.1. Partial Pressures of Respiratory Gases.html", "keywords": ""}, {"title": "11.04.2. Classification of Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.04.2. Classification of Ventilation.html", "keywords": "alveolar physiological total anatomical volume gas or dead measuring pressure ratio tidal and to ventilation composition partial equation carbon space hypoventilation minute of hyperventilation dioxide"}, {"title": "11.04.3. Ventilatory Pattern, Dead Space, and Alveolar Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.04.3. Ventilatory Pattern, Dead Space, and Alveolar Ventilation.html", "keywords": ""}, {"title": "11.05.4. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.05.4. Points to Remember.html", "keywords": ""}, {"title": "11.05. Pulmonary Function Measurements", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.05. Pulmonary Function Measurements.html", "keywords": ""}, {"title": "11.06. Pulmonary Blood Flow", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.06. Pulmonary Blood Flow.html", "keywords": ""}, {"title": "11.07. Gas Diffusion", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.07. Gas Diffusion.html", "keywords": ""}, {"title": "11.08. Oxygen Equilibrium & Transport", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.08. Oxygen Equilibrium & Transport.html", "keywords": ""}, {"title": "11.09. Carbon Dioxide Equilibrium & Transport", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.09. Carbon Dioxide Equilibrium & Transport.html", "keywords": ""}, {"title": "11.10 Acid-Base Regulation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.10 Acid-Base Regulation.html", "keywords": ""}, {"title": "11.11. Control of Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.11. Control of Ventilation.html", "keywords": ""}, {"title": "11.12. Ventilation-Perfusion Relationships", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.12. Ventilation-Perfusion Relationships.html", "keywords": ""}, {"title": "11.13. Clinical Assessment of Acid-Base & Oxygenation Status", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.13. Clinical Assessment of Acid-Base & Oxygenation Status.html", "keywords": ""}, {"title": "11.14. Physiological Basis for Oxygenation and Lung Protection Strategies", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.14. Physiological Basis for Oxygenation and Lung Protection Strategies.html", "keywords": ""}, {"title": "11.15. Physiology of Sleep-Disordered Breathing", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.15. Physiology of Sleep-Disordered Breathing.html", "keywords": ""}, {"title": "11.16. Fetal & Newborn Cardiopulmonary Physiology", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.16. Fetal & Newborn Cardiopulmonary Physiology.html", "keywords": ""}, {"title": "12. Pulmonary Symptoms", "url": "/Pulmonary Medicine/12. Pulmonary Symptoms.html", "keywords": ""}, {"title": "Critical Care Medicine", "url": "/Critical Care Medicine.html", "keywords": "oncologic medicine administration critical neurologic hematologic renal ethics ultrasound | endocrine research research%2c transplantation surgery%2c and metabolic gastrointestinal toxicology disorders md trauma surgery - cardiovascular care trauma%2c endocrine%2c scanning pharmacology topics renal%2c"}, {"title": "Cardiovascular Disorders", "url": "/Critical Care Medicine/Cardiovascular Disorders.html", "keywords": ""}, {"title": "Critical Care Ultrasound Scanning", "url": "/Critical Care Medicine/Critical Care Ultrasound Scanning.html", "keywords": ""}, {"title": "Gastrointestinal Disorders", "url": "/Critical Care Medicine/Gastrointestinal Disorders.html", "keywords": ""}, {"title": "Hematologic and Oncologic Disorders", "url": "/Critical Care Medicine/Hematologic and Oncologic Disorders.html", "keywords": ""}, {"title": "Neurologic Disorders", "url": "/Critical Care Medicine/Neurologic Disorders.html", "keywords": ""}, {"title": "Pharmacology and Toxicology", "url": "/Critical Care Medicine/Pharmacology and Toxicology.html", "keywords": ""}, {"title": "Renal, Endocrine, and Metabolic Disorders", "url": "/Critical Care Medicine/Renal, Endocrine, and Metabolic Disorders.html", "keywords": ""}, {"title": "Research, Administration and Ethics", "url": "/Critical Care Medicine/Research, Administration and Ethics.html", "keywords": ""}, {"title": "Surgery, Trauma, and Transplantation", "url": "/Critical Care Medicine/Surgery, Trauma, and Transplantation.html", "keywords": ""}, {"title": "Signs & Symptoms", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/Index/Signs & Symptoms.html", "keywords": "symptoms wheezing medicine index signs cough dyspnea pulmonary lung md 3 1 01 obstructive %26 2 disease"}]